Long Term Effects of Raloxifene Treatment on Bone Quality

Osteoporosis, Post-Menopausal Clinical Trial

Official title:
Long-Term Effects of Raloxifene Treatment on Bone Quality: A Cross-Sectional Study of Postmenopausal Women With Osteoporosis Previously Enrolled in the Continuing Outcomes Relevant to Evista Study

Status Completed

Clinical Trial Summary

This is a cross-sectional study to determine, via iliac crest bone biopsies, the effect of long-term treatment with raloxifene on histomorphometry and bone quality in patients who participated in the Continuing Outcomes Relevant to Evista Study.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00532428
Study type	Interventional
Source	Eli Lilly and Company
Contact
Status	Completed
Phase	Phase 4
Start date	April 2003
Completion date	September 2003

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00532207` - Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis	Phase 3
Completed	`NCT00018447` - Combination Osteogenic Therapy in Established Osteoporosis	Phase 2
Completed	`NCT00532246` - Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo	Phase 4
Completed	`NCT00543023` - A Study of the Treatment of Postmenopausal Women With Osteoporosis	Phase 3
Completed	`NCT00927186` - Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women	Phase 4
Completed	`NCT00543218` - PTH Comparison in Post Menopausal Women	Phase 3
Completed	`NCT00532545` - Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis	Phase 4